CHICAGO--(BUSINESS WIRE)--Fitch Ratings has assigned an 'A' rating to Eli Lilly's Euro notes offering. Fitch expects the company to use the net proceeds of the issuance for general corporate purposes, including the possible pay down of existing debt. The Rating Outlook is Stable. KEY RATING DRIVERS --Lilly is nearing the end of its significant patent risk period that essentially began in 2014 with two of its top drugs, which accounted for roughly 26% of total firm sales, losing patent protectio
| < Prev | Next > |
|---|
